Animal & Veterinary

AquAdvantage Salmon

FDA has issued for public comment a draft environmental assessment (EA) related to the agency’s review of an application concerning AquAdvantage Salmon, a genetically engineered Atlantic salmon. FDA’s preliminary finding is that an approval of this application, under the specific conditions proposed in the application, would not have a significant impact (FONSI) on the U.S. environment. AquAdvantage Salmon is a product of AquaBounty Technologies (AquaBounty), of Maynard, Mass. 

Page Last Updated: 05/18/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.